Minimal Residual Disease in Chronic Lymphocytic Leukemia : The Current and Evolving Treatment Paradigm
WebcastFaculty
OVERVIEW
Minimal Residual Disease in Chronic Lymphocytic Leukemia : The Current and Evolving Treatment Paradigm is organized by prIME oncology Oncology and will be held during Apr 19, 2017 - Apr 19, 2018.
The target audience for this medical event is specifically designed to meet the needs of hematologists, medical oncologists, nurses, and other healthcare professionals involved in the treatment of patients with CLL. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Objectives are :
After completion of this educational activity, participants should be able to:
• Identify optimal practices for MRD evaluation, including appropriate definition, methods, and timing of analysis
• Evaluate clinical trial data providing insight into the use of MRD status in the management of CLL
Additional details will be posted as soon as they are available.
The target audience for this medical event is specifically designed to meet the needs of hematologists, medical oncologists, nurses, and other healthcare professionals involved in the treatment of patients with CLL. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Objectives are :
After completion of this educational activity, participants should be able to:
• Identify optimal practices for MRD evaluation, including appropriate definition, methods, and timing of analysis
• Evaluate clinical trial data providing insight into the use of MRD status in the management of CLL
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyHematology Blood and Marrow Transplant
Quick Links